German China

UK: Precision Nanoparticles Dolomite and Mologic Collaborate to Develop Rapid Covid-19 Diagnostic Tests

Editor: Ahlam Rais

Mologic has recently received funding from the UK Government to develop a test for Covid-19 which can generate results within minutes. For this purpose, the company has tied up with Dolomite Microfluidics in order to scale-up precision nanoparticles which are vital for this project.

Related Vendor

Dolomite is working with Mologic to combine ground-breaking diagnostic technology with continuous flow microfluidic manufacturing processes for Mologic’s Covid-19 diagnostic test.
Dolomite is working with Mologic to combine ground-breaking diagnostic technology with continuous flow microfluidic manufacturing processes for Mologic’s Covid-19 diagnostic test.
(Source: Dolomite Microfluidics)

UK – As the Covid-19 pandemic progresses in countries around the globe, there is an urgent need for rapid and reliable point-of-need detection testing. Dolomite Microfluidics and Mologic are working together to accelerate the development and launch of these tests.

UK-based company Mologic is a leading developer of rapid response diagnostic tests for diseases such as malaria and Ebola virus disease. Clients include the Bill & Melinda Gates Foundation, where Mologic is leveraging its core technology through its Centre for Advanced Rapid Diagnostics (Card) to develop the next generation of ultra-sensitive point-of-care diagnostics which are easy to use and inexpensive to manufacture – critical to the success of many global health programmes.

Most recently, Mologic has received UK Government funding to develop and manufacture a high sensitivity test for Covid-19 that generates results within minutes – rather than hours or days – without the need for a laboratory or specialist equipment.

The technology behind these tests involves the use of precisely manufactured nanoparticles. Dolomite specialises in equipment that allows the development and scale-up of precision nanoparticles. This is achieved by using microfluidic technology to retain advanced control of production conditions.

Dolomite is working with Mologic to combine ground-breaking diagnostic technology with continuous flow microfluidic manufacturing processes to accelerate the validation and release of Mologic’s Covid-19 diagnostic test.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:46500556)